BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 9703926)

  • 1. Identification of optimal conditions for the detection of benzo[a]pyrene-DNA adducts by enzyme-linked immunoadsorbent assays (ELISA).
    Bucci F; Galati R; Zito R; Falasca G; Federico A; Verdina A
    Anticancer Res; 1998; 18(4A):2669-74. PubMed ID: 9703926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of specific humoral immunity on DNA-adduct formation in Swiss mice treated with benzo[alpha]pyrene.
    Galati R; Falasca G; Verdina A
    Anticancer Res; 1999; 19(3A):2101-4. PubMed ID: 10470155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of (7S,8R)-dihydroxy-(9R,10S)-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene adducts in human serum albumin by laser-induced fluorescence: implications for the in vivo metabolism of benzo[a]pyrene.
    Ozbal CC; Skipper PL; Yu MC; London SJ; Dasari RR; Tannenbaum SR
    Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):733-9. PubMed ID: 10919745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An improved fluorometric assay for dosimetry of benzo(a)pyrene diol-epoxide-DNA adducts in smokers' lung: comparisons with total bulky adducts and aryl hydrocarbon hydroxylase activity.
    Alexandrov K; Rojas M; Geneste O; Castegnaro M; Camus AM; Petruzzelli S; Giuntini C; Bartsch H
    Cancer Res; 1992 Nov; 52(22):6248-53. PubMed ID: 1423269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-performance liquid chromatography electrospray ionization tandem mass spectrometry for the detection and quantitation of benzo[a]pyrene-DNA adducts.
    Beland FA; Churchwell MI; Von Tungeln LS; Chen S; Fu PP; Culp SJ; Schoket B; Gyorffy E; Minárovits J; Poirier MC; Bowman ED; Weston A; Doerge DR
    Chem Res Toxicol; 2005 Aug; 18(8):1306-15. PubMed ID: 16097804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of DNA and globin adducts of polynuclear aromatic hydrocarbon diol epoxides by gas chromatography-mass spectrometry and -3H-CH3I postlabeling of released tetraols.
    Melikian AA; Sun P; Coleman S; Amin S; Hecht SS
    Chem Res Toxicol; 1996 Mar; 9(2):508-16. PubMed ID: 8839056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The binding efficiency of polyclonal and monoclonal antibodies to DNA modified with benzo[a]pyrene diol epoxide is dependent on the level of modification. Implications for quantitation of benzo[a]pyrene-DNA adducts in vivo.
    Van Schooten FJ; Kriek E; Steenwinkel MJ; Noteborn HP; Hillebrand MJ; Van Leeuwen FE
    Carcinogenesis; 1987 Sep; 8(9):1263-9. PubMed ID: 3113753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA adduct formation in mouse tissues in relation to serum levels of benzo(a)pyrene-diol-epoxide after injection of benzo(a)pyrene or the diol-epoxide.
    Ginsberg GL; Atherholt TB
    Cancer Res; 1990 Feb; 50(4):1189-94. PubMed ID: 2105163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective digestion and novel cleanup techniques for detection of benzo[a]pyrene diol epoxide-DNA adducts by capillary electrophoresis/mass spectrometry.
    Gennaro LA; Vadhanam M; Gupta RC; Vouros P
    Rapid Commun Mass Spectrom; 2004; 18(14):1541-7. PubMed ID: 15282777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of benzo[a]pyrene-DNA adducts from leukocytes from heavy smokers.
    Arnould JP; Hermant A; Levi-Valensi P; Belegaud J
    Pathol Biol (Paris); 1998 Dec; 46(10):787-90. PubMed ID: 9922995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential removal of DNA adducts derived from anti-diol epoxides of dibenzo[a,l]pyrene and benzo[a]pyrene in human cells.
    Dreij K; Seidel A; Jernström B
    Chem Res Toxicol; 2005 Apr; 18(4):655-64. PubMed ID: 15833025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoaffinity chromatography of carcinogen DNA adducts with polyclonal antibodies directed against benzo[a]pyrene diol-epoxide-DNA.
    Tierney B; Benson A; Garner RC
    J Natl Cancer Inst; 1986 Jul; 77(1):261-7. PubMed ID: 3459918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of 32P-postlabelling and immunological methods to examine human lung DNA for benzo[a]pyrene adducts.
    Garner RC; Tierney B; Phillips DH
    IARC Sci Publ; 1988; (89):196-200. PubMed ID: 3143669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of humoral immunity against adducted benzo[a]pyrene on DNA damage elicited by acute carcinogen exposure in Swiss mice.
    Galati R; Crebelli R; Zijno A; Conti L; Falasca G; Verdina A
    In Vivo; 2000; 14(6):747-51. PubMed ID: 11204493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity to DNA damage induced by benzo(a)pyrene diol epoxide and risk of lung cancer: a case-control analysis.
    Li D; Firozi PF; Wang LE; Bosken CH; Spitz MR; Hong WK; Wei Q
    Cancer Res; 2001 Feb; 61(4):1445-50. PubMed ID: 11245449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benzo[a]pyrene-7,8-quinone-3'-mononucleotide adduct standards for 32P postlabeling analyses: detection of benzo[a]pyrene-7,8-quinone-calf thymus DNA adducts.
    Balu N; Padgett WT; Nelson GB; Lambert GR; Ross JA; Nesnow S
    Anal Biochem; 2006 Aug; 355(2):213-23. PubMed ID: 16797471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding efficiency of antibodies to DNA modified with aromatic amines and polycyclic aromatic hydrocarbons: implications for quantification of carcinogen-DNA adducts in vivo.
    Kriek E; Van Schooten FJ; Hillebrand MJ; Welling MC
    IARC Sci Publ; 1988; (89):201-7. PubMed ID: 3143670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative in vitro and in vivo benzo[a]pyrene-DNA adduct formation and its relationship to CYP1A activity in two species of ictalurid catfish.
    Ploch SA; King LC; Kohan MJ; Di Giulio RT
    Toxicol Appl Pharmacol; 1998 Mar; 149(1):90-8. PubMed ID: 9512731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of stereospecificity of benzo[a]pyrene diolepoxide-DNA antisera with site-specifically modified oligonucleotides.
    Hsu TM; Liu TM; Amin S; Geacintov NE; Santella RM
    Carcinogenesis; 1995 Sep; 16(9):2263-5. PubMed ID: 7554088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 32P-postlabeling assay in mice of transplacental DNA damage induced by the environmental carcinogens safrole, 4-aminobiphenyl, and benzo(a)pyrene.
    Lu LJ; Disher RM; Reddy MV; Randerath K
    Cancer Res; 1986 Jun; 46(6):3046-54. PubMed ID: 3698023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.